GET THE APP

Ligusticum wallichii elevates the proliferation of hypoxia-stimul | 33968
Pediatrics & Therapeutics

Pediatrics & Therapeutics
Open Access

ISSN: 2161-0665

+44 1478 350008

Ligusticum wallichii elevates the proliferation of hypoxia-stimulated human microglia through promoting HIF-1α-mediated MET expression


2nd Global Congress and Expo on Pediatric Cardiology & Healthcare

September 22-24, 2016 Las Vegas, USA

Chun Ming Jiang, You Peng, Xiang Fang, Xiao Hua Wang, Jin Shu, Liang Hua Zhu, Wei Xia Yang, Li Li Zhuang and Guo Ping Zhou

The First Affiliated Hospital of Nanjing Medical University, China
The Affiliated Hospital of Nantong University, China

Scientific Tracks Abstracts: Pediat Therapeut

Abstract :

During the hypoxia-involved neonatal stroke, microglial cells take part in endogenous defense mechanisms to prevent the brain injury. Thus, the reasonable therapeutic intervention in this disease may be the increase of microglia proliferation. In our study, we primarily found that Ligusticum wallichii enhances the proliferation of hypoxia-stimulated human microglia by increasing the cell cycle. Furthermore, Ligusticum wallichii differentially regulated the expression of a lot of genes, in which MET gene, encoding a cell surface receptor tyrosine kinase for recognizing hepatocyte growth factor ligand, acts an important down-stream effective molecule for Ligusticum wallichii in treatment with hypoxia-induced human microglia by using RNAi technique. Moreover, Ligusticum wallichii enhances the binding of HIF-1�?± to the promoter of MET gene in hypoxia-treated human microglia, providing the rational explanation why Ligusticum wallichii plus hypoxia-administrated human microglia have highest MET expression. Collectively, we have identified a potential mechanism by which MET regulated by HIF-1�?± contributes to Ligusticum wallichii-mediated increase of proliferation of hypoxia-induced human microglia. Thus Ligusticum wallichii and targeting MET should be considered as two potential strategies for enhancing the hypoxia-stimulated human microglia.

Biography :

Chun Ming Jiang has completed his MM from Wenzhou Medical University and MD studies from Nanjing Medical University of Medicine. He is the Attending Doctor and Senior Researcher of the Affiliated Hangzhou Hospital of Nanjing Medical University. He has published more than 10 papers in peer-reviewed journals and has been serving as an Editorial Board Member of repute.

Email: cm_jiang@126.com

Top